研究简报

万古霉素衍生物——特拉万星的合成方法改进

  • 刘泺 ,
  • 潘敏 ,
  • 周静珊 ,
  • 杨金纬
展开
  • 浙江医药股份有限公司新昌制药厂 绍兴 312500

收稿日期: 2015-05-18

  修回日期: 2015-06-18

  网络出版日期: 2015-07-02

Process Improvement on the Synthesis of Telavancin-Derivative of Vancomycin

  • Liu Luo ,
  • Pan Min ,
  • Zhou Jinshan ,
  • Yang Jinwei
Expand
  • Zhejiang Medicine Co., Ltd. Xinchang Pharma, Shaoxing 312500

Received date: 2015-05-18

  Revised date: 2015-06-18

  Online published: 2015-07-02

摘要

将特拉万星的合成路线进行了工艺改进, 通过连续反应方法制得关键中间体N-Fmoc-癸基氨基乙醛, 然后经一锅法及曼尼希反应, 反相硅胶制备得到特拉万星盐酸盐. HPLC纯度及收率均高于已有文献报道, 且整条路线操作简便, 成本更低, 环境友好, 适于工业化生产.

本文引用格式

刘泺 , 潘敏 , 周静珊 , 杨金纬 . 万古霉素衍生物——特拉万星的合成方法改进[J]. 有机化学, 2015 , 35(11) : 2437 -2440 . DOI: 10.6023/cjoc201505029

Abstract

This article was the process improvement of telavancin synthesis. The key intermediate N-Fmoc-decyl-amino- acetaldehyde was obtained through continuous reaction method, followed by one-pot condensation and Mannich reaction. Telavancin hydrochloride was finnally obtained via reversed phase silica gel. The HPLC purity and total yield of this route were higher than the existing literatures. It was easy to operate, environmentally friendly, lower costs, and suitable for industrialized production.

参考文献

[1] Chang, M. H.; Kish, T. D.; Fung, H. B. Clin. Ther. 2010, 32(13), 2160.
[2] Shang, X. Y.; Ruan, L. J. Chin. J. Ant. 2007, 32, 263 (in Chinese). (尚新艳, 阮丽军, 中国抗生素杂志, 2007, 32, 263.)
[3] Lee, J.; Liu, J. WO 03018607, 2003 [Chem. Abstr. 2003, 138, 205347].
[4] Liang, Y. H.; Feng, W. H. Chin. J. Synth. Chem. 2011, 19(4), 550 (in Chinese). (梁玉华, 冯文化, 合成化学, 2011, 19(4), 550.)
[5] Ma, S.; Cao, S. H. Chin. J. New Drugs 2013, 22(23), 2809 (in Chinese). (马帅, 曹胜华, 中国新药杂志, 2013, 22(23), 2809.)
[6] Michael, R. L.; Stacy, M. A.; Bettina. B. J. Ant. 2004, 57(5), 326.
[7] Liu, J; Lee, J. US 20050113561, 2005 [Chem. Abstr. 2005, 142, 451926].
[8] Leadbetter, M.; Linsell, M.; Lee, J.; Liu, J. WO 2003029270, 2003 [Chem. Abstr. 2003, 138, 287982].)

文章导航

/